menu search

ITRM / Iterum Therapeutics to Present Data at IDWeek 2023

Iterum Therapeutics to Present Data at IDWeek 2023
DUBLIN, Ireland and CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that three posters will be presented at the Infectious Disease Society of America's IDWeek 2023 conference taking place in Boston, MA from October 11-15, 2023. Read More
Posted: Oct 12 2023, 09:15
Author Name: GlobeNewsWire
Views: 091988

ITRM News  

Iterum Therapeutics to Present Data at IDWeek 2023

By GlobeNewsWire
October 12, 2023

Iterum Therapeutics to Present Data at IDWeek 2023

DUBLIN, Ireland and CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c more_horizontal

Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023

By GlobeNewsWire
August 4, 2023

Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023

DUBLIN, Ireland and CHICAGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c more_horizontal

Iterum Therapeutics to Present Data at ASM Microbe 2023

By GlobeNewsWire
June 12, 2023

Iterum Therapeutics to Present Data at ASM Microbe 2023

DUBLIN, Ireland and CHICAGO, June 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c more_horizontal

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023

By GlobeNewsWire
March 9, 2023

Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023

DUBLIN, Ireland and CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical more_horizontal

Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today?

By InvestorPlace
July 11, 2022

Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today?

Iterum Therapeutics (ITRM) stock is taking off on Monday as investors react to news of a clinical trial agreement with the FDA. The post Why Is Iterum more_horizontal

Iterum Therapeutics plc (ITRM) CEO Corey Fishman on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 28, 2022

Iterum Therapeutics plc (ITRM) CEO Corey Fishman on Q4 2021 Results - Earnings Call Transcript

Iterum Therapeutics plc (ITRM) CEO Corey Fishman on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: